ライフサイエンスコーパス: gastrointestinal disorder

1 disorders of teeth and jaw, fractures, upper gastrointestinal disorders).

2 rgens (e.g., food allergies and eosinophilic gastrointestinal disorders).

3 bowel syndrome (IBS) is a chronic functional gastrointestinal disorder.

4 ategory of abdominal pain-related functional gastrointestinal disorder.

5 Irritable bowel syndrome (IBS) is a common gastrointestinal disorder.

6 drome (IBS) is a highly prevalent functional gastrointestinal disorder.

7 acid reflux into the esophagus, is a common gastrointestinal disorder.

8 remodeling is a hallmark of the pathology of gastrointestinal disorders.

9 sorders (ASD) predominantly in patients with gastrointestinal disorders.

10 ole on gastric emptying (GE) in a variety of gastrointestinal disorders.

11 inflammatory bowel disease and in functional gastrointestinal disorders.

12 cial role in the diagnosis and management of gastrointestinal disorders.

13 across a diverse array of both affective and gastrointestinal disorders.

14 he 2 most common conditions among functional gastrointestinal disorders.

15 um of 1 year) to assess for incident chronic gastrointestinal disorders.

16 he bacterial microbiota in dogs with various gastrointestinal disorders.

17 e potential utility of microbe discovery for gastrointestinal disorders.

18 ted with visceral hyperalgesia in functional gastrointestinal disorders.

19 evention and treatment of a variety of human gastrointestinal disorders.

20 in children with pain-predominant functional gastrointestinal disorders.

21 regarding the use of rifaximin for different gastrointestinal disorders.

22 f distress in adult patients with functional gastrointestinal disorders.

23 ore than 30 other countries for a variety of gastrointestinal disorders.

24 d important in pain perception in functional gastrointestinal disorders.

25 elationship to reflux disease and functional gastrointestinal disorders.

26 derstanding of both organic and 'functional' gastrointestinal disorders.

27 sensitivity, is often observed in functional gastrointestinal disorders.

28 ic procedures used to deal with a variety of gastrointestinal disorders.

29 or the treatment of patients with functional gastrointestinal disorders.

30 tailor treatment to children with functional gastrointestinal disorders.

31 armacology of medications used in functional gastrointestinal disorders.

32 derstanding of both organic and 'functional' gastrointestinal disorders.

33 enteric pathogen responsible for a number of gastrointestinal disorders.

34 ologies associated with diverse vascular and gastrointestinal disorders.

35 important part of therapy for several common gastrointestinal disorders.

36 III criteria for the diagnosis of functional gastrointestinal disorders.

37 e mediation of both visceral nociception and gastrointestinal disorders.

38 from this site may play a role in recurrent gastrointestinal disorders.

39 bers of adverse experiences, including upper-gastrointestinal disorders.

40 o, an increased risk of cognitive, mood, and gastrointestinal disorders.

41 most frequently isolated and associated with gastrointestinal disorders.

42 unction is linked to a range of debilitating gastrointestinal disorders.

43 e status, comorbidity count, and presence of gastrointestinal disorders.

44 Dyspepsia is a common complaint in upper gastrointestinal disorders.

45 discuss the evidence for a role of stress in gastrointestinal disorders.

46 therapeutic application of peptide drugs in gastrointestinal disorders.

47 of 314 with dolutegravir), mainly driven by gastrointestinal disorders.

48 g haematological, infectious, autoimmune and gastrointestinal disorders.

49 ding to low birth weight, and predisposes to gastrointestinal disorders.

50 ] of 24 assigned to placebo), 207 (37%) were gastrointestinal disorders.

51 bioelectronic neuromodulation therapies for gastrointestinal disorders.

52 ticipants; most events were mild or moderate gastrointestinal disorders.

53 inistered peptide drugs for the treatment of gastrointestinal disorders.

54 therefore have potential as a biomarker for gastrointestinal disorders.

55 olic syndrome, diabetes, liver diseases, and gastrointestinal disorders.

56 e (IBS) is one of the most common functional gastrointestinal disorders.

57 cents with abdominal pain-related functional gastrointestinal disorders.

58 g gut microbiota and reduces weaning-related gastrointestinal disorders.

59 athophysiological research in the functional gastrointestinal disorders.

60 and gut and could lead to new treatments for gastrointestinal disorders.

61 s with each other and the host in functional gastrointestinal disorders.

62 vity and abdominal pain associated with many gastrointestinal disorders.

63 ed to the trial medication, seven (50%) were gastrointestinal disorders.

64 uggests that it might contribute to neonatal gastrointestinal disorders.

65 to understand dysfunctions in the functional gastrointestinal disorders.

66 d may explain comorbid conditions, including gastrointestinal disorders.

67 known about the effects of air pollution on gastrointestinal disorders.

68 < .001), and 0 of 8 patients with unrelated gastrointestinal disorders.

69 order (OR 2.72, 95% CI 1.09-6.81, p=0.0323), gastrointestinal disorders (1.94, 1.03-3.65, p=0.0390),

70 d host defence, and is often dysregulated in gastrointestinal disorders(1).

71 omes colonized, which-in some cases-leads to gastrointestinal disorders(1-4).

72 erse events were lymphopenia (12 [100%]) and gastrointestinal disorders (11 [92%]).

73 ), hearing loss (11.8%; 95% CI, 5.5%-21.3%), gastrointestinal disorders (11.8%; 95% CI, 5.2%-21.8%),

74 The most common adverse events were gastrointestinal disorders (12 patients [30%] in the RO5

75 mmon adverse events were infections (18.0%), gastrointestinal disorders (13.0%) and hematological tox

76 ssions for nonpulmonary diagnoses, including gastrointestinal disorders (14 admissions), cardiovascul

77 nate group and 46 in the placebo group), and gastrointestinal disorders (15 in the amoxicillin-clavul

78 ommon treatment-emergent adverse events were gastrointestinal disorders (17 [77%] participants in the

79 verse events (p=0.122); the most common were gastrointestinal disorders (174 [68%] vs 180 [69%]) and

80 12 [8%]), diarrhoea (16 [10%] vs four [3%]), gastrointestinal disorders (18 [11%] vs 12 [8%]), and ha

81 (21.4%) patients reported 341 AEs, primarily gastrointestinal disorders (19.6%).

82 ] of 240 patients in the busulfan group) and gastrointestinal disorders (24 [11%] patients vs 39 [16%

83 of 96 patients in the chemotherapy group) or gastrointestinal disorders (28 [29%] vs 20 [21 %]).

84 vs. 47%), as were the rates of grade 3 or 4 gastrointestinal disorders (28% vs. 7%) and infections (

85 eight patients [28%] in the placebo group), gastrointestinal disorders (34 [61%] vs eight [28%]), in

86 0% vs 73.1%), mainly (as expected) blood and gastrointestinal disorders; 4% of patients reported grad

87 lated treatment-emergent adverse events were gastrointestinal disorders (60 [47%] in the pirfenidone

88 ronic constipation is a prevalent functional gastrointestinal disorder accompanied with intestinal dy

89 Eosinophilic gastrointestinal disorders, also known as eosinophilic g

90 colitis (NEC) is the most common and serious gastrointestinal disorder among preterm neonates.

91 Functional gastrointestinal disorders and fatigue may follow acute

92 es in the gut may increase susceptibility to gastrointestinal disorders and infection, and impact cri

93 on adverse events related to plerixafor were gastrointestinal disorders and injection site reactions.

94 tly been more used for patients with diffuse gastrointestinal disorders and preserved hepatic functio

95 nths of life reduced the onset of functional gastrointestinal disorders and reduced private and publi

96 ovide insights into the pathogenesis of many gastrointestinal disorders and the development of therap

97 explained symptoms of GWI include functional gastrointestinal disorders and undiagnosed illnesses, in

98 disorders, but higher risk for pancreatitis, gastrointestinal disorders, and arthritis.

99 tion, on diseases such as cancer, infection, gastrointestinal disorders, and asthma.

100 ch as inflammatory bowel disease, functional gastrointestinal disorders, and colon cancer occur.

101 most common adverse events were infections, gastrointestinal disorders, and cytopenias.

102 osive gastrointestinal disorders, nonerosive gastrointestinal disorders, and disorders involving incr

103 disorders in understanding adult functional gastrointestinal disorders, and encouraging clinical and

104 mune diseases, such as rheumatoid arthritis, gastrointestinal disorders, and myocardial ischemia.

105 Impaired renal function, gastrointestinal disorders, and neurological complicatio

106 processes, including infections, asthma, and gastrointestinal disorders, and new data concerning gene

107 3 or worse vascular disorders, two (1%) had gastrointestinal disorders, and two (1%) patients had gr

108 health conditions, such as sleep disorders, gastrointestinal disorders, and vision problems.

109 Rome III "abdominal pain related functional gastrointestinal disorders" (AP-FGID) has been changed t

110 Functional gastrointestinal disorders are among the most common med

111 Functional gastrointestinal disorders are complex symptom-based dis

112 Functional gastrointestinal disorders are defined as conditions in

113 e future, treatment approaches to functional gastrointestinal disorders are likely to become more per

114 Symptoms of functional gastrointestinal disorders are often triggered by meal i

115 and motor functions in health and functional gastrointestinal disorders are reviewed.

116 Considering that gastrointestinal disorders are the most common side effe

117 mucosal barrier, and secretion in functional gastrointestinal disorders as well as effects of food, m

118 High-quality trials of probiotics in gastrointestinal disorders as well as laboratory investi

119 his group included patients with symptomatic gastrointestinal disorders as well as nonsymptomatic vol

120 as been proven to be associated with several gastrointestinal disorders as well as potential effects

121 This plant is used for the treatment of gastrointestinal disorders, as it possesses antitumorige

122 is an enteropathogenic bacterium that causes gastrointestinal disorders, as well as extraintestinal m

123 ritable bowel syndrome (IBS) is a functional gastrointestinal disorder associated with intestinal dys

124 bowel syndrome (IBS) is a common functional gastrointestinal disorder associated with significant di

125 rone may be a therapeutic target in treating gastrointestinal disorders associated with alterations i

126 inhibitors may provide novel treatments for gastrointestinal disorders associated with dysregulation

127 group and in 3.0% in the placebo group, with gastrointestinal disorders being the most common reason

128 ease is one of the most prevalent autoimmune gastrointestinal disorders, but as the case of Ms J illu

129 in is used to treat patients with functional gastrointestinal disorders, but little is known about it

130 strategies aimed at managing methane-related gastrointestinal disorders by harnessing the power of th

131 Patients with functional gastrointestinal disorders can feel stigmatised, and oft

132 fistulizing Crohn's disease (CD) is a severe gastrointestinal disorder causing extensive mucosal dama

133 bowel syndrome (IBS) is a common functional gastrointestinal disorder characterized by abdominal dis

134 Irritable bowel syndrome (IBS) is a common gastrointestinal disorder characterized by abdominal pai

135 Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by abdominal pai

136 Gastroparesis is a chronic gastrointestinal disorder characterized by delayed gastr

137 ital lactase deficiency is an extremely rare gastrointestinal disorder characterized by neonatal-onse

138 rritable bowel syndrome (PI-IBS) is a common gastrointestinal disorder characterized by persistent ab

139 Functional dyspepsia (FD) is a gastrointestinal disorder characterized by recurrent and

140 microbiome, gut epithelial permeability, and gastrointestinal disorders contribute to heart failure p

141 roducts as therapeutics in acute and chronic gastrointestinal disorders could be effective.

142 crobiota has also been studied in functional gastrointestinal disorders; data remain inconclusive.

143 Functional dyspepsia (FD) is a functional gastrointestinal disorder diagnosed by symptom-based cri

144 rients but often avoided by individuals with gastrointestinal disorders, due to high levels of fermen

145 the world with fecal incontinence and other gastrointestinal disorders, educates physicians through

146 46; psoriasis, OR, 1.13; 95% CI, 1.05-1.21), gastrointestinal disorders (eg, gastroesophageal reflux,

147 The most frequent adverse events were gastrointestinal disorders (eg, nausea, constipation, an

148 -mediated food allergy (FA) and eosinophilic gastrointestinal disorders (EGID) are clinically distinc

149 Food allergy (FA) and eosinophilic gastrointestinal disorders (EGIDs) are driven by similar

150 Eosinophilic gastrointestinal disorders (EGIDs) are hypersensitivity

151 atment benefit in patients with eosinophilic gastrointestinal disorders (EGIDs) beyond eosinophilic e

152 nabinoids acting on CB1 receptors in chronic gastrointestinal disorders, especially in refractory chr

153 Rumination syndrome (RS) is a functional gastrointestinal disorder (FGD) increasingly recognized

154 to identify the risk of new onset functional gastrointestinal disorders (FGD) and gastroesophageal re

155 were identified with one of these functional gastrointestinal disorders (FGDs), compared with 6% of c

156 Functional gastrointestinal disorders (FGID) are common in the comm

157 Functional gastrointestinal disorders (FGID) are defined by a combi

158 l framework for understanding the functional gastrointestinal disorders (FGID) from a biopsychosocial

159 Functional gastrointestinal disorders (FGID) including impaired rec

160 Patients with functional gastrointestinal disorders (FGID) often experience emoti

161 sence and severity of symptoms of functional gastrointestinal disorders (FGID), the "7*7" questionnai

162 genotype is associated with lower functional gastrointestinal disorders (FGID).

163 Functional gastrointestinal disorders (FGIDs) are closely related t

164 Functional gastrointestinal disorders (FGIDs) are common conditions

165 ation of childhood and adolescent functional gastrointestinal disorders (FGIDs) has evolved during th

166 Functional gastrointestinal disorders (FGIDs) have prominent sex di

167 Patients with functional gastrointestinal disorders (FGIDs) often experience dist

168 een the intestinal microbiome and functional gastrointestinal disorders (FGIDs), and independently an

169 Functional gastrointestinal disorders (FGIDs), now known as disorde

170 ncreasingly used for treatment of functional gastrointestinal disorders (FGIDs), now recognized as di

171 Functional gastrointestinal disorders (FGIDs), the most common diag

172 cated in symptoms associated with functional gastrointestinal disorders (FGIDs), though mechanisms re

173 e (IBS) is one of the most common functional gastrointestinal disorders (FGIDs), which has now been r

174 to the Rome II classification of functional gastrointestinal disorders (FGIDs).

175 ct of sleep problems in pediatric functional gastrointestinal disorders (FGIDs).

176 n the psychosocial aspects of the functional gastrointestinal disorders (FGIDs).

177 ter database to evaluate the risk of several gastrointestinal disorders following select foodborne in

178 iteria for abdominal pain-related functional gastrointestinal disorders from a single US outpatient g

179 ce, characteristics, and risk factors of new gastrointestinal disorders (GID) associated with SARS-Co

180 ldren between 0 and 18 years with underlying gastrointestinal disorders had been treated for concomit

181 ent years, association of vacA genotypes and gastrointestinal disorders has attracted a lot of attent

182 aser endomicroscopy and in-vivo diagnosis of gastrointestinal disorders has increased in the last few

183 NK) B and NK3 receptors in visceral pain and gastrointestinal disorders has not been determined.

184 the Rome III definition of functional upper gastrointestinal disorders has refined the concept of NE

185 Recent insights in the field of functional gastrointestinal disorders have opened the way for novel

186 patients with short bowel syndrome and other gastrointestinal disorders, however long-term use may le

187 probiotics is widely extended in the case of gastrointestinal disorders; however, their use in microb

188 There was an increased risk of gastrointestinal disorders, hypotension, syncope, arthri

189 The International Foundation for Functional Gastrointestinal Disorders (IFFGD) is a nonprofit educat

190 Feline chronic enteropathy (CE) is a common gastrointestinal disorder in cats and mainly comprises i

191 ndrome (CVS) is a well-recognized functional gastrointestinal disorder in children but its presentati

192 reflux disease (GERD) is the most prevalent gastrointestinal disorder in the United States, and lead

193 classes and symptoms, with the exception of gastrointestinal disorders in 21 (81%) of 23 patients in

194 y no report that describes the prevalence of gastrointestinal disorders in a representative group of

195 ficacy for abdominal pain-related functional gastrointestinal disorders in adolescents.

196 The symptoms from functional gastrointestinal disorders in children younger than 5 ye

197 the treatment of pain-predominant functional gastrointestinal disorders in children.

198 R activity is considered as the key cause of gastrointestinal disorders in cystic fibrosis including

199 perfringens causes severe, sometimes lethal gastrointestinal disorders in humans, including enteriti

200 al center for the diagnosis and follow-up of gastrointestinal disorders in southern Italy (ie, Bari,

201 a, seen at a specialized unit for functional gastrointestinal disorders in Sweden from 2002 through 2

202 valuation of the risks and 1-year burdens of gastrointestinal disorders in the post-acute phase of CO

203 ARS-CoV-2 infection are at increased risk of gastrointestinal disorders in the post-acute phase of CO

204 is the leading cause of hospitalization for gastrointestinal disorders in the United States.

205 e leading cause of admission to hospital for gastrointestinal disorders in the USA and many other cou

206 izing the importance of childhood functional gastrointestinal disorders in understanding adult functi

207 ew treatment strategies for a broad range of gastrointestinal disorders, including constipation, pseu

208 dverse events, mostly of mild severity, were gastrointestinal disorders, including diarrhoea (18 [4%]

209 latory influence of histamine on a number of gastrointestinal disorders, including food allergy, scom

210 ns, these drugs also frequently cause severe gastrointestinal disorders, including mucosal erosions,

211 esity to common and debilitating hepatic and gastrointestinal disorders, including nonalcoholic steat

212 r have potential for treatment of functional gastrointestinal disorders, including psychopharmacologi

213 rogen (H(2)) cycling in the gut is linked to gastrointestinal disorders, infections and cancers.

214 cy of antithrombotic agents in patients with gastrointestinal disorders is challenging because of the

215 The pathophysiology of functional gastrointestinal disorders is complex, but involves bidi

216 arly robust clinical evidence for other rare gastrointestinal disorders is needed.

217 paediatric abdominal pain-related functional gastrointestinal disorders is needed.

218 Mild gastrointestinal disorders, jaundice resulting from isol

219 Rates of gastrointestinal disorders, jaundice, dry skin, and phot

220 ions, diagnostic support, and treatments for gastrointestinal disorders like IBS.

221 tabolic disorders, cardiovascular disorders, gastrointestinal disorders, malaise, fatigue, musculoske

222 ication of abdominal pain-related functional gastrointestinal disorders might help to select children

223 Some gastrointestinal disorders might therefore be treated wi

224 ssociated with the development of functional gastrointestinal disorders, most commonly irritable bowe

225 Gastrointestinal disorders, most commonly nausea, were t

226 siology and symptom generation of functional gastrointestinal disorders needs to be further studied a

227 bdominal pain (2.48, 1.61-3.81, p<0.0001), a gastrointestinal disorder (non-surgical 2.32, 1.51-3.56,

228 e primary causes can be divided into erosive gastrointestinal disorders, nonerosive gastrointestinal

229 an organic disorder or some other functional gastrointestinal disorder (not related to abdominal pain

230 Grade 3 skin and gastrointestinal disorders occurred in four (17%) and tw

231 Serious gastrointestinal disorders occurred more frequently with

232 e events, most commonly minor infections and gastrointestinal disorders, occurred in more than 95% of

233 Drug-related skin and gastrointestinal disorders of any grade occurred in 35 (

234 licobacter pylori is responsible for several gastrointestinal disorders, of which gastric cancer is t

235 ent or rupture (two [3%] vs one [1%]), upper gastrointestinal disorders (one [1%] vs two [3%]), dista

236 the treatment or investigation of functional gastrointestinal disorders or disease models need to hav

237 Underlying gastrointestinal disorder (OR, 4.7; 95% CI, 1.1-20.9; P

238 l abuse and lifetime diagnosis of functional gastrointestinal disorders (OR, 2.43; 95% CI, 1.36-4.31;

239 R, 3.27; 95% CI, 1.02-10.53), and functional gastrointestinal disorders (OR, 4.01; 95% CI, 1.88-8.57)

240 ciation in subjects with ASD with or without gastrointestinal disorders (P > 0.05).

241 ld revolutionize the treatment of functional gastrointestinal disorders, particularly IBS.

242 al and some clinical data to link functional gastrointestinal disorders pathogenesis to disturbances

243 to play a role in postinfectious functional gastrointestinal disorders (PI-FGIDs).

244 Functional gastrointestinal disorders present diagnostic and therap

245 volved other pancreatic disorders, diabetes, gastrointestinal disorders, sarcopenia and osteopenia, c

246 able bowel syndrome (IBS) is the most common gastrointestinal disorder significantly decreasing patie

247 ic disorders (SR, 1.52 [95% CI, 1.31-1.75]), gastrointestinal disorders (SR, 2.00 [95% CI, 1.04-1.38]

248 [3%] of 90, dabigatran two [1%] of 176), and gastrointestinal disorders (standard of care two [2%] of

249 Rome IV criteria for functional gastrointestinal disorders state that children suspected

250 XFP4 axis is a promising target for treating gastrointestinal disorders such as constipation.

251 orders, as has been described for functional gastrointestinal disorders such as IBS and functional dy

252 n recent times, the perception of functional gastrointestinal disorders such as irritable bowel syndr

253 pathogenic biofilms that have been linked to gastrointestinal disorders such as irritable bowel syndr

254 Inflammatory and functional gastrointestinal disorders such as irritable bowel syndr

255 ople will be labelled as having a functional gastrointestinal disorder, such as irritable bowel syndr

256 Infectious complications and gastrointestinal disorders, such as failure to thrive an

257 of the most common reasons for patients with gastrointestinal disorders, such as inflammatory bowel d

258 and symptom severity (Patient Assessment of Gastrointestinal Disorders Symptom Severity Index) measu

259 ssment using the patient assessment of upper gastrointestinal disorders-symptom severity index (PAGI-

260 (SIBO), and the Patient Assessment of Upper Gastrointestinal Disorders Symptoms (PAGI-SYM) and Compo

261 This is a chronic, debilitating gastrointestinal disorder that affects ruminants and is

262 bowel syndrome (IBS) is a commonly diagnosed gastrointestinal disorder that can have a substantial im

263 ancreatitis (AP) is a common and devastating gastrointestinal disorder that causes significant morbid

264 Diverticulitis is a prevalent gastrointestinal disorder that is associated with signif

265 HD is a congenital gastrointestinal disorder that requires surgical resecti

266 to inflammatory bowel disorders, a group of gastrointestinal disorders that can produce serious recu

267 s during disease or injury may underlie many gastrointestinal disorders that currently have unknown e

268 constipation are the most common functional gastrointestinal disorders that lead to referral to a pe

269 thors examine the differential diagnosis for gastrointestinal disorders that should be considered in

270 ellbeing and symptom reporting in functional gastrointestinal disorders; the presence of anxiety or d

271 have been implicated in the pathogenesis of gastrointestinal disorders, their function has not been

272 wel syndrome (IBS), which is the most common gastrointestinal disorder, there may be disturbances at

273 With the high prevalence of gastrointestinal disorders, there is great interest in e

274 Gallstone disease (GSD) is a common gastrointestinal disorder throughout the world.

275 velopment of both metabolic dysfunctions and gastrointestinal disorders, thus gut dysbiosis in IBS ma

276 istic pathogen causing diseases ranging from gastrointestinal disorders to severe liver abscesses.

277 se events with naltrexone-bupropion included gastrointestinal disorders, tremor, malaise, hyperhidros

278 lpha3 and evaluate its associations with the gastrointestinal disorders UC, CD and CRC, in comparison

279 oval of oral GUCY2C ligands to treat chronic gastrointestinal disorders underscores the potential the

280 50.3% in the placebo group; the incidence of gastrointestinal disorders was 5.0% and 4.4%, respective

281 conference of experts in zinc nutrition and gastrointestinal disorders was convened to consider appr

282 ange of protective effects of Sb in multiple gastrointestinal disorders, we hypothesize that Sb modul

283 ldren with abdominal pain-related functional gastrointestinal disorders were enrolled and assigned to

284 More gastrointestinal disorders were reported with liraglutid

285 rom patients with pain associated functional gastrointestinal disorders were retrospectively reviewed

286 Gastrointestinal disorders were the most common adverse

287 Gastrointestinal disorders were the most common adverse

288 Gastrointestinal disorders were the most frequently repo

289 Functional gastrointestinal disorders, which have visceral hypersen

290 etween-group differences were largely due to gastrointestinal disorders, which were more common with

291 Gastrointestinal disorders, which were mostly mild to mo

292 ritable bowel syndrome (IBS) is a functional gastrointestinal disorder whose hallmark is abdominal pa

293 onal constipation is a prevalent, burdensome gastrointestinal disorder whose treatment remains challe

294 well as prognostic and diagnostic tools for gastrointestinal disorders, will be greatly facilitated

295 Irritable bowel syndrome is a functional gastrointestinal disorder with symptoms including abdomi

296 Irritable bowel syndrome (IBS) is a common gastrointestinal disorder with symptoms of abdominal pai

297 bowel syndrome is classified as a functional gastrointestinal disorder with the primary symptom of ab

298 atory disease, and is one of the most common gastrointestinal disorders worldwide.

299 owel syndrome (IBS) is among the most common gastrointestinal disorders worldwide.

300 Studies of motility and functional gastrointestinal disorders would be feasible without the